2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Infection, Meningococcal: new trials by email Literature Review of Infection, Meningococcal trials Research Report on Infection, Meningococcal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old EuNmCV-5, Menveo - Infection, Meningococcal | Phase 1 | Completed | EuBiologics Co.,Ltd | 60 | 2023-02-28 | 2023-12-20 |
| Safety and Immunogenicity of Meningococcal Conjugate Vaccine in Healthy Adults Aged 19 to 55 Years Old Meningococcal(Groups A, C, W-135, and Y) Conjugate Vaccine, Meningococcal(Groups A, C, Y, and W-135) Conjugate Vaccine - Infection, Meningococcal | Phase 1 | Completed | EuBiologics Co.,Ltd | 60 | 2020-09-01 | 2021-10-07 |
Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Gram-Negative Bacterial Infections (2) · Infections (2) · Neisseriaceae Infections (2)
Meningococcal Vaccines (2) · Vaccines, Conjugate (2)
South Korea (2)